Re: Morgan Stanley GHC Event
Although I'm not a big fan of anecdotal evidence (e.g. A for FA reports), off label use of Methotrexate with K showed 100% results. What is not appreciated by the market (at all) is that K is all about the number of vials per patient. Even for those who go on K, many do not finish treatment and I believe the average is something like 6 vials used. There is still plenty of benefit to those who get the treatment but can't complete it, so that is not an issue, but increased vials means many more $$$$ (not figured currently into the equation). There is also the possibility that use of immuno modulator could allow for retreatment (something that is now at Zero), should tofu should CRG recur in patients.